Supreme Court

Pharmalot Ed Silverman

STAT Plus: Allergan and a Mohawk tribe ask the Supreme Court to review their controversial patent deal

Politics Ike Swetlitz

STAT Plus: Supreme Court to examine a common legal strategy drug makers use to sidestep patient lawsuits

Pharmalot Ed Silverman

STAT Plus: Supreme Court to decide a patent case with big implications for small drug makers

Pharmalot Ed Silverman

STAT Plus: Supreme Court agrees to review Merck case with broad implications for consumer lawsuits

Pharmalot Ed Silverman

STAT Plus: Solicitor general urges Supreme Court to review Merck case about warnings

Pharmalot Ed Silverman

STAT Plus: Supreme Court rules California cannot hang a welcome sign for pharma lawsuits

Pharmalot Ed Silverman

STAT Plus: Supreme Court rules to allow lower-cost biosimilars to market faster in Sandoz-Amgen case

Politics Lev Facher

STAT Plus: Trump’s Supreme Court pick is deeply opposed to assisted suicide

Biotech Meghana Keshavan

STAT Plus: Supreme Court agrees to review biosimilar launch rules

Politics Shanoor Seervai

Mississippi’s only abortion clinic gets renewed hope after Supreme Court decision

The Pharmalot View Ed Silverman

STAT Plus: Drug industry overstates impact of patent reviews on innovation

Politics David Nather

STAT Plus: Supreme Court strikes down Texas abortion clinic regulations

Pharmalot Ed Silverman

Supreme Court asks Obama administration for views on biosimilar rules

Politics Dylan Scott

Supreme Court’s ruling in patent case a blow to drug industry

Politics Associated Press

STAT Plus: Supreme Court avoids major ruling in birth control dispute

Politics Dylan Scott

STAT Plus: Supreme Court skeptical in case backed by drug makers

Politics Dylan Scott

STAT Plus: Why an obscure Supreme Court case is a big deal for prescription drugs

First Opinion Nina Wells

A nurse speaks out: Religious freedom is no excuse for denying contraceptives

First Opinion Yevgeniy Feyman and Austin Frakt

Supreme Court delivers a blow to health care cost transparency

Pharmalot Ed Silverman

STAT Plus: Supreme Court declines to hear J&J appeal of Children’s Motrin lawsuit

Politics Dylan Scott

Justice Scalia: Aspiring black scientists may do better in ‘lesser schools’